These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27957197)

  • 1. Heart Failure With Reduced Ejection Fraction And A Narrow QRS Complex: Combination Of A Subcutaneous Defibrillator With Cardiac Contractility Modulation.
    Röger S; Borggrefe M; Kuschyk J
    J Atr Fibrillation; 2015; 8(3):1081. PubMed ID: 27957197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction.
    Röger S; Rudic B; Akin I; Shchetynska-Marinova T; Fastenrath F; Tülümen E; Liebe V; El-Battrawy I; Baumann S; Kuschyk J; Borggrefe M
    Clin Cardiol; 2018 Apr; 41(4):518-524. PubMed ID: 29697870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac contractility modulation and subcutaneous defibrillator (S-ICD): First experience with simultaneous implantation.
    Yao J; Gao J; Yan JF; Fang S
    Pacing Clin Electrophysiol; 2023 Dec; 46(12):1595-1598. PubMed ID: 36938703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device interaction between cardiac contractility modulation (CCM) and subcutaneous defibrillator (S-ICD).
    Trolese L; Faber T; Gressler A; Steinfurt J; Stuplich J; Jordan E; Bode C; Zehender M; Hilgendorf I
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3095-3098. PubMed ID: 34379359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.
    Kuschyk J; Stach K; Tülümen E; Rudic B; Liebe V; Schimpf R; Borggrefe M; Röger S
    Heart Rhythm; 2015 Nov; 12(11):2230-8. PubMed ID: 26073595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Cardiac Contractility Modulation Electrodes on Tricuspid Regurgitation in Patients with Heart Failure with Reduced Ejection Fraction: A Pilot Study.
    Masarone D; Kittleson MM; De Vivo S; D'Onofrio A; Rao I; Ammendola E; Errigo V; Martucci ML; Nigro G; Pacileo G
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator.
    Groh CA; Sharma S; Pelchovitz DJ; Bhave PD; Rhyner J; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP
    Heart Rhythm; 2014 Aug; 11(8):1361-6. PubMed ID: 24755323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.
    Nägele H; Behrens S; Eisermann C
    Europace; 2008 Dec; 10(12):1375-80. PubMed ID: 18776196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrillators: Selecting the Right Device for the Right Patient.
    Al-Khatib SM; Friedman P; Ellenbogen KA
    Circulation; 2016 Nov; 134(18):1390-1404. PubMed ID: 27799257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Generation Cardiac Contractility Modulation Device-Filling the Gap in Heart Failure Treatment.
    Tint D; Florea R; Micu S
    J Clin Med; 2019 Apr; 8(5):. PubMed ID: 31035648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac contractility modulation. A new form of therapy for patients with heart failure and narrow QRS complex?].
    Kleemann T
    Herz; 2015 Nov; 40(7):945-51. PubMed ID: 26446549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.
    Verma N; Rhyner J; Knight BP
    Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
    Sanghera R; Sanders R; Husby M; Bentsen JG
    Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.